1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Nucleic Acid Amplification Detection and Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Nucleic Acid ; Process ; Product Type ; Technology ; Application ; End User, and Geography

Nucleic Acid Amplification Detection and Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Nucleic Acid ; Process ; Product Type ; Technology ; Application ; End User, and Geography

  • November 2020
  • 350 pages
  • ID: 6010080
  • Format: PDF
  • The Insight Partners
Up to $1700 off Until Feb 28th 2021

Summary

Table of Contents

Search Inside

The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors such as increasing prevalence of infectious diseases and rising demand for advanced diagnostic systems. However, lack of adequate infrastructure in emerging countries is estimated to hamper the growth of the market during the forecast period.

The nucleic acid amplification is one of the important tools used among life science technologies such as clinical medicine development, diagnosis of infectious diseases, and gene cloning.Increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems.

Continuous R&D activities, significant investments, and focus on development of reagents and kits formulations for nucleic acid amplification technologies hold substantial potential to provide rapid and reliable diagnosis compared to other IVD (In-Vitro Diagnostics) tests. Moreover, various players have developed integrated, portable, and micro-fluidics based platforms with an aim to increase the functionality of diagnostic analysis and sensing. bioMerieux’s NucliSENS easyQ tests and Enigma Diagnostics’s MiniLab are some of the systems that offer microfluidics-based platforms, which are cost-effective and user-friendly.

Increasing number of investments and collaborations are playing a vital role in the development of advanced diagnostic kits and instruments.Additionally, the pharmaceutical companies and research institutes are emphasizing on utilizing nucleic acid amplification technologies, as they offer superior precession in disease diagnosis.

For instance, in June 2020, Shionogi & Co., Ltd., a significant player in Japan pharmaceutical market entered into strategic collaboration with Gunma University, Nihon University, and Tokyo Medical University for the development of modernized diagnostic system for the detection of infectious diseases. This collaboration will exclusively work on signal amplification method in order to develop rapid test product.

The potential of nucleic acid amplification technology is also being accepted by the healthcare professionals during the unprecedented times of COVID-19 pandemic, which represents the superiority of this technology over other IVD techniques.Additionally, the acceptance of nucleic acid amplification technology is accelerating the number of product launches.

For instance, in April 2020, Hologic, Inc. announced a launch of Aptima molecular assay for diagnosis of COVID-19. The newly launched product incorporates transcription-mediated amplification (TMA) technique. Such developments represent significant demand for nucleic acid amplification detection and diagnosis, which will eventually drive the market growth during the forecast period.

Based on nucleic acid, the nucleic acid amplification, detection, and diagnostics market is segmented into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). In 2019, the deoxyribonucleic acid (DNA) segment held the largest share of the market; also, the same segment is likely to witness the fastest growth during the forecast period.

Based on process, the nucleic acid amplification, detection, and diagnostics market is segmented into diagnostics, amplification, and detection.The amplification segment is further sub-segmented as transcription-mediated amplification (TMA), loop-mediated isothermal amplification (LMIA), strand displacement amplification (SDA), helicase-dependent amplification (HDA), nucleic acid sequence-based amplification (NASBA), and others.

The diagnostics segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Based on product type, the nucleic acid amplification, detection, and diagnostics market is segmented into kits & reagents, assays, and systems. The kits & reagents segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Based on technology, the nucleic acid amplification, detection, and diagnostics market is segmented into polymerase chain reaction (PCR), next generation sequencing (NGS), isothermal amplification technology, direct nucleic acid detection, and CRISPR-Cas9.The polymerase chain reaction (PCR) segment is further sub-segmented as Quantitative PCR (qPCR), reverse-transcriptase (RT–PCR), multiplex PCR, nested PCR, in-situ PCR, and others.

In addition, isothermal amplification technology segment is sub-segmented as target amplification systems, probe amplification systems, and signal amplification systems.Direct nucleic acid detection segment is further sub-segmented as aptamers, DNA biosensors, and others.

The polymerase chain reaction (PCR) segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Based on application, the nucleic acid amplification, detection, and diagnostics market is segmented into infectious diseases, genetic diseases, oncology, forensic testing, paternity testing, and others. The infectious diseases segment held the largest share of the market in 2019; whereas, oncology segment is estimated to register the fastest growth during the forecast period.

Based on end user, the nucleic acid amplification, detection, and diagnostics market is segmented into hospital & clinics, diagnostic centers, research institutes, and others. The hospital & clinics segment held the largest share of the market in 2019; whereas, research institutes is estimated to register the fastest growth during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), NHS (National Health Service), and Centers for Disease Control and Prevention are among the major primary and secondary sources referred for preparing this report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

$4500

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Point of Care/Rapid Diagnostics Market by Product, Platform, Mode of Purchase, Enduser - Global Forecast to 2025

  • $ 4950
  • February 2021
  • 232 pages

The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point ...

  • World
  • North America
  • Diagnostics
  • Industry analysis
  • Drug Approval
  • Diabetes Prevalence

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on